Search Results - "Perroni, D."

Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter Study by AMADORI, D, NANNI, O, GIUNCHI, D. C, TIENGHI, A, BECCIOLINI, A, VOLPI, A, MARANGOLO, M, PACINI, P, RAVAIOLI, A, ROSSI, A, GAMBI, A, CATALANO, G, PERRONI, D, SCARPI, E

“…According to one of the most recent key scientific questions concerning the use of biomarkers in clinical trials, we investigated whether node-negative breast…”
Get full text

Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial by Dogliotti, L, Berruti, A, Buniva, T, Zola, P, Baù, M G, Farris, A, Sarobba, M G, Bottini, A, Alquati, P, Deltetto, F, Gosso, P, Monzeglio, C, Moro, G, Sussio, M, Perroni, D

“…Some evidence in vitro and in vivo shows that lonidamine (LND) can positively modulate the activity of doxorubicin and epirubicin (EPI). On this basis, a…”
Get more information

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival by Berruti, A, Zola, P, Buniva, T, Baù, M G, Farris, A, Sarobba, M G, Bottini, A, Tampellini, M, Durando, A, Destefanis, M, Monzeglio, C, Moro, G, Sussio, M, Perroni, D, Dogliotti, L

“…Randomized trials suggest that the outcome of metastatic breast cancer (BC) patients is not affected by the currently available therapies. Although response…”
Get more information

Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients by Bretti, S., Berruti, A., Gorzegno, G., La Ciura, P., Pazè, E., Celano, A., Grecchi, G., Perroni, D., Bumma, C., Dogliotti, L.

“…Vinorelbine (VNB) and cisplatin (CDDP) combination regimen was found active in the treatment of advanced non-small cell lung cancer (NSCLC) patients, but…”
Get full text

Right ventricular metastasis from choriocarcinoma: report of a rare case and review of the literature by Perroni, D, Grecchi, G L, La Ciura, P, Landoni, F

“…A previously healthy gravida developed chest pain and progressive dyspnea several months after delivery. A right ventricular mass rising from the septum and…”
Get more information

Impact of Follow-up Testing on Survival and Health-Related Quality of Life in Breast Cancer Patients: A Multicenter Randomized Controlled Trial by Ghezzi, P, Magnanini, S, Rinaldini, M, Berardi, F, Di Biagio, G, Testare, F, Tavoni, N, Schittulli, F, D'Amico, C, Pedicini, T, Fumagalli, M, Gritti, G, Braga, M, Marini, G, Zaniboni, A, Cosentino, D, Epifani, C, Gini, G, Perroni, D, Peradotto, F, Indelli, M, Santini, A, Isa, L, Aitini, E, Cavazzini, G, Smerieri, F, Nascimben, O, Busolin, R, Papaccio, G, Locatelli, E, Monti, M, Ghislandi, E, Gottardi, O, Majno, M, Pluchinotta, A, Armaroli, L, Confalonieri, C, Viola, P, Galletto, L, Sussio, M, Trolli, B, Biasio, M, Rolfo, A, Vaudano, G, Giolito, M. R, Ambrosini, G, Busana, L, Molteni, M, Richetti, A, Marubini, E, Piffanelli, A, Salvadori, B, Tognoni, G, Zola, P, Liberati, A, Fossati, R, Meyerowitz, B. E, Torri, V, Apolone, G, Mosconi, P, Marsoni, S, Liberati, M. C, Alexanian, A, Grilli, R, Nicolucci, A, Monferroni, N

“…Objective.—To assess prospectively the impact on survival and health-related quality of life of two follow-up protocols in patients with early breast…”
Get full text

ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer

“…A series of meta-analyses of randomised controlled trials raised the question of whether the three-drug combination of CAP (cyclophosphamide, doxorubicin, and…”
Get full text

Phase II trial of continuous/metronomic 5-fluorouracil infusion plus long acting Octreotide in advanced neuroendocrine carcinoma by Dogliotti, L., Brizzi, M. P., Ferrero, A., Milanesi, E., Ciuffreda, L., Castiglione, F., Bombaci, S., Perroni, D., Alabiso, O., Berruti, A.

“…Abstract only 15003 Background: The administration of cytotoxic drugs on a metronomic schedule has shown antiangiogenetic properties. Well differentiated…”
Get full text

Growth hormone and somatomedin behaviour in the newborn by Giodano, G, Foppiani, E, Minuto, F, Perroni, D

“…Human growth hormone (HGH) and somatomedin (Sm) concentrations have been studied in a group of newborns. Plasma HGH values were 41.17 +/- 24.26 (SD) ng/ml…”
Get more information

What doctors tell patients with breast cancer about diagnosis and treatment: findings from a study in general hospitals

Get full text

Osteoid osteoma of the femur neck (report of a case) by Odella, F, Schiesari, L, Gaetani, G, Simoncini, F, Perroni, D

“…After presentation of statistical data on the incidence of osteoid osteoma, a case of femoral neck localization is presented with details of medical history,…”
Get more information

Neo-adjuvant chemotherapy by Bumma, C, Perroni, D, Grecchi, G L, Lauria, G, Pautasso, M

Get more information